The Healy Dilemma: A Reply to the American College of Neuropsychopharmacology's Report on SSRIs and Suicidal Behavior in Children

Leo, Jonathan
July 2004
Ethical Human Psychology & Psychiatry;Summer2004, Vol. 6 Issue 2, p147
Academic Journal
In response to the growing media awareness of the potential link between SSRIs and increased thoughts of suicide in children. The American College of Neuropsycho pharmacology (ACNP) recently released an executive summary from its task force assigned to investigate this question (ACNP, 2004). Their Executive Summary, released just days before the FDA hearing on this issue, explains that there is no link between SSRIs and suicide, yet they ignore the work of David Healy, the most recent critic of the flawed methodology of the clinical trials investigation. The ANCP's summary essentially provides a framework for how the FDA should not proceed with its own investigation. The following article is a response to the ANCP.


Related Articles

  • FDA mulls stronger warning for antidepressants. Johnsen, Michael // Drug Store News;10/11/2004, Vol. 26 Issue 13, p8 

    Reports on the issuance of a black-box warning on the use of antidepressants among children and adolescents by the U.S. Food and Drug Administration. Connection of antidepressants on suicidal behavior of children; Continuation of publicity and public awareness; Endorsement of a patient...

  • Antidepressants' Black Box Warning: Doing More Harm than Good?  // Journal of Psychosocial Nursing & Mental Health Services;Feb2007, Vol. 45 Issue 2, p10 

    The article offers information on "black box" warnings issued by the U.S. Food and Drug Administration (FDA) about the increase in suicide risk among children receiving antidepressant agents. A proposal endorsed by the advisory panel of the FDA during the December 13, 2006 hearing on adult...

  • ANTIDEPRESSANT UPS SUICIDE RISK IN ADULTS.  // Ecologist;Jul/Aug2006, Vol. 36 Issue 6, p14 

    The article reports that Seroxat can cause adults as well as children to become suicidal. Seroxat is the best-selling anti-depressant in the Great Britain. GlaxoSmithKline (GSK), manufacturer of Seroxat, has long been denying that there was a problem wit the drug. GSK was forced to admit the...

  • Drugs for Depression May Trigger Suicidal Thoughts, Acts in Children at Risk for Bipolar Disorder, Says Parent Group.  // Ascribe Newswire: Medicine;2/4/2004, p9 

    Drugs for depression may trigger suicidal thoughts, acts in children at risk for bipolar disorder. The Child and Adolescent Bipolar Foundation (CABF) on behalf of its 17,000 member families, called for the federal Food and Drug Administration to add black box warnings to certain medications used...

  • US panel recommends 'black box' warnings for antidepressants. Check, Erika // Nature Medicine;Oct2004, Vol. 10 Issue 10, p1005 

    Reports on the call to the U.S. Food and Drug Administration to add tough warnings to antidepressant medications, due to the finding that the drugs cause some children to become suicidal. Advisory committee's voting in favor of a so-called "black-box" warning that would inform patients and...

  • Will British Ban Spur FDA to Act? O'Meara, Kelly Patricia // Insight on the News;2/17/2004, Vol. 20 Issue 5, p26 

    Discusses the decision of the British Committee of Safety of Medicines (CSM) to ban the use of antidepressants for children in Great Britain. Antidepressants reviewed by the CSM; Suicidal risks attributed to antidepressant drugs; Move made by the U.S. Food and Drug Administration to ascertain...

  • How Well Does The Press Cover Medication Risks?  // Child Health Alert;Feb2010, Vol. 28, p2 

    The article discusses the reliability of press releases regarding medication risks. One identified topic of a press release given out by the U.S. Food and Drug Administration (FDA) is suicidalilty or the risk of suicidal thinking and suicide attempts in children brought about by antidepressant...

  • Drug Warning. Wade, Courtney K. // Education Week;10/27/2004, Vol. 24 Issue 9, p4 

    This article presents information on a drug warning issued by the U.S. Food and Drug Administration (FDA). Citing the increased risk of suicidal thoughts and behavior in some, children and adolescents who use anti-depressants, the U.S. FDA issued a public-health advisory Ocober 15 saying a...

  • SSRJs and Suicide-What Effect Has the Black Box Warning Had? Spittler, Karen L. // Neuropsychiatry Reviews;Sep2008, Vol. 9 Issue 9, p1 

    The article examines the effects of untreated depression on the suicidal tendency of children and adolescents. It highlights the studies which link suicides with depression. According to Charles Nemeroff, MD, PhD, many people who commit suicide have untreated depression. It also cites the move...


Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics